BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 22370882)

  • 1. Immunohistochemical and molecular analysis of caveolin-1 expression in canine mammary tumors.
    Zuccari DA; Castro R; Gavioli AF; Mancini UM; Frade CS; Leonel C
    Genet Mol Res; 2012 Jan; 11(1):153-65. PubMed ID: 22370882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical expression of caveolin-1 in normal and neoplastic canine mammary tissue.
    Amorim I; Lopes CC; Faustino AM; Pereira PD
    J Comp Pathol; 2010 Jul; 143(1):39-44. PubMed ID: 20153867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caveolin-1 in diagnosis and prognosis of canine mammary tumours: comparison of evaluation systems.
    Pereira PD; Lopes CC; Matos AJ; Cortez PP; Gärtner F; Medeiros R; Lopes C
    J Comp Pathol; 2010; 143(2-3):87-93. PubMed ID: 20153868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p63: a novel myoepithelial cell marker in canine mammary tissues.
    Gama A; Alves A; Gartner F; Schmitt F
    Vet Pathol; 2003 Jul; 40(4):412-20. PubMed ID: 12824513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression of p63 and cytokeratin 5 in mixed tumors of the canine mammary gland provides new insights into the histogenesis of these neoplasms.
    Ramalho LN; Ribeiro-Silva A; Cassali GD; Zucoloto S
    Vet Pathol; 2006 Jul; 43(4):424-9. PubMed ID: 16846983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-8 expression associated with canine mammary tumors.
    Zuccari DA; Castro R; Gelaleti GB; Mancini UM
    Genet Mol Res; 2011; 10(3):1522-32. PubMed ID: 21863548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of hormone receptor expression for use in predicting survival of female dogs with malignant mammary gland tumors.
    Chang CC; Tsai MH; Liao JW; Chan JP; Wong ML; Chang SC
    J Am Vet Med Assoc; 2009 Aug; 235(4):391-6. PubMed ID: 19681719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the oncogene c-erbB-2 in canine mammary cancers and tumor-derived cell lines.
    Ahern TE; Bird RC; Bird AE; Wolfe LG
    Am J Vet Res; 1996 May; 57(5):693-6. PubMed ID: 8723884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of C5a receptor (CD88) mRNA in canine mammary tumors.
    Hezmee MN; Kyaw-Tanner M; Lee JY; Shiels IA; Rolfe B; Woodruff T; Mills PC
    Vet Immunol Immunopathol; 2011 Jan; 139(1):50-6. PubMed ID: 20846729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation and overexpression of p53 as a prognostic factor in canine mammary tumors.
    Lee CH; Kim WH; Lim JH; Kang MS; Kim DY; Kweon OK
    J Vet Sci; 2004 Mar; 5(1):63-9. PubMed ID: 15028887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of caveolin-1 and matrix metalloproteinase 14 gene expression in canine mammary tumours.
    Ebisawa M; Iwano H; Nishikawa M; Tochigi Y; Komatsu T; Endou Y; Hirayama K; Taniyama H; Kadosawa T; Yokota H
    Vet J; 2015 Nov; 206(2):191-6. PubMed ID: 26364240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and prognostic significance of CK19 in canine malignant mammary tumours.
    Gama A; Alves A; Schmitt F
    Vet J; 2010 Apr; 184(1):45-51. PubMed ID: 19264518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammary cancer in the dog: a study of 120 cases.
    Mulligan RM
    Am J Vet Res; 1975 Sep; 36(9):1391-6. PubMed ID: 169716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous mammary intraepithelial lesions in dogs--a model of breast cancer.
    Antuofermo E; Miller MA; Pirino S; Xie J; Badve S; Mohammed SI
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2247-56. PubMed ID: 17982119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and significance of PTEN in canine mammary gland tumours.
    Qiu C; Lin D; Wang J; Wang L
    Res Vet Sci; 2008 Oct; 85(2):383-8. PubMed ID: 18082231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secreted frizzled-related protein 2 (SFRP2) is highly expressed in canine mammary gland tumors but not in normal mammary glands.
    Lee JL; Chang CJ; Wu SY; Sargan DR; Lin CT
    Breast Cancer Res Treat; 2004 Mar; 84(2):139-49. PubMed ID: 14999144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical expression of Epidermal Growth Factor Receptor (EGFR) in canine mammary tissues.
    Gama A; Gärtner F; Alves A; Schmitt F
    Res Vet Sci; 2009 Dec; 87(3):432-7. PubMed ID: 19464036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caveolin-1, mammary stem cells, and estrogen-dependent breast cancers.
    Sotgia F; Rui H; Bonuccelli G; Mercier I; Pestell RG; Lisanti MP
    Cancer Res; 2006 Nov; 66(22):10647-51. PubMed ID: 17108100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-associated carbohydrate antigens: Sialyl Lea and T/Tn antigens in canine mammary tumors.
    Nowak M; Madej J; Dziegiel P; Lopuszynski W; Rodo A; Ugorski M
    Vet Pathol; 2009 Mar; 46(2):222-6. PubMed ID: 19261632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progesterone receptor isoform analysis by quantitative real-time polymerase chain reaction in formalin-fixed, paraffin-embedded canine mammary dysplasias and tumors.
    Guil-Luna S; Stenvang J; Brünner N; Sánchez-Céspedes R; Millán Y; Gómez-Laguna J; de las Mulas JM
    Vet Pathol; 2014 Sep; 51(5):895-902. PubMed ID: 24249219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.